AlphaStar Capital Management’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,099
Closed -$182K 253
2025
Q4
$182K Buy
12,099
+258
+2% +$10.2K 0.01% 245
2025
Q3
$171K Buy
11,841
+400
+3% +$14.5K 0.01% 193
2025
Q2
$163K Buy
11,441
+739
+7% +$26.8K 0.01% 354
2025
Q1
$159K Sell
10,702
-12,437
-54% -$493K 0.02% 181
2024
Q4
$333K Buy
+23,139
New +$924K 0.03% 159

Other funds holding BME

AlphaStar Capital Management's BME Position: Q1 2026 in Review

AlphaStar Capital Management sold out of BlackRock Health Sciences Trust (BME) in Q1 2026, closing a stake of 12,099 shares — an estimated $182K sold.

AlphaStar Capital Management first reported a position in BME in Q4 2024 and held it in 5 quarters. The position peaked at $333K in Q4 2024. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • AlphaStar Capital Management reported no remaining BlackRock Health Sciences Trust position as of Q1 2026 after selling out during the quarter.
  • AlphaStar Capital Management sold 12,099 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $182K.
  • AlphaStar Capital Management first reported a position in BlackRock Health Sciences Trust in Q4 2024 and held it in 5 quarters.
  • AlphaStar Capital Management's BlackRock Health Sciences Trust position peaked at $333K in Q4 2024.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on AlphaStar Capital Management's 13F filing for Q1 2026, filed 15 Apr 2026.